PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16377053-3	2006	In mice neonatally treated with monosodium L-glutamate to produce GH-deficiency, GH was found to be an essential factor with GH archetype as a determinant in the regulatory mechanism of hepatic CYP2D9 and CYP3A41 expression, and GH was shown to be a repressive factor for the constitutive expression in females.	Sodium Glutamate	32-54	growth hormone	Mus musculus	66-68	
16377053-3	2006	In mice neonatally treated with monosodium L-glutamate to produce GH-deficiency, GH was found to be an essential factor with GH archetype as a determinant in the regulatory mechanism of hepatic CYP2D9 and CYP3A41 expression, and GH was shown to be a repressive factor for the constitutive expression in females.	Sodium Glutamate	32-54	growth hormone	Mus musculus	81-83	
16377053-3	2006	In mice neonatally treated with monosodium L-glutamate to produce GH-deficiency, GH was found to be an essential factor with GH archetype as a determinant in the regulatory mechanism of hepatic CYP2D9 and CYP3A41 expression, and GH was shown to be a repressive factor for the constitutive expression in females.	Sodium Glutamate	32-54	growth hormone	Mus musculus	81-83	
8161351-0	1994	Effects of neonatally administered monosodium glutamate on the sexually dimorphic profiles of circulating growth hormone regulating murine hepatic monooxygenases.	Sodium Glutamate	35-55	growth hormone	Mus musculus	106-120	
16547391-3	2006	The extensive decline of CYP2D9 mRNA expression becoming a sexually non-specific P450 in 9-week-old male mice exposed as neonates to monosodium L-glutamate (MSG) suggested that the male GH secretion pattern is a key to the regulation of male-specific CYP2D9 mRNA expression in adult mice.	Sodium Glutamate	157-160	growth hormone	Mus musculus	186-188	
9175714-2	1997	The 2- to 3-fold higher activities in adult male mice compared with adult female mice were decreased to the female levels by neonatal pretreatment with monosodium glutamate (MSG) or monosodium aspartate (MSA), either of which is known to reduce circulating GH levels.	Sodium Glutamate	152-172	growth hormone	Mus musculus	257-259	
9175714-2	1997	The 2- to 3-fold higher activities in adult male mice compared with adult female mice were decreased to the female levels by neonatal pretreatment with monosodium glutamate (MSG) or monosodium aspartate (MSA), either of which is known to reduce circulating GH levels.	Sodium Glutamate	174-177	growth hormone	Mus musculus	257-259	
3830732-0	1985	Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally.	Sodium Glutamate	131-151	growth hormone	Mus musculus	92-106